Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912113236> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W2912113236 endingPage "413" @default.
- W2912113236 startingPage "403" @default.
- W2912113236 abstract "The studies reported here aimed to assess the safety and tolerability of cetirizine ophthalmic solution 0.24%, a new topical ophthalmic medication approved by the US Food and Drug Administration for the treatment of ocular itching associated with allergic conjunctivitis.Three clinical studies evaluated cetirizine ophthalmic solution 0.24% administration: a Phase I prospective, single-center, open-label, pharmacokinetic (PK) study (N=11) evaluating single-dose administration and twice-daily (BID) administration for 1 week in healthy adults, and two Phase III, multi-center, randomized, double-masked, vehicle-controlled, parallel-group studies evaluating the safety and tolerability in adult and pediatric populations (2-18 years of age) for up to 6 consecutive weeks. The first safety and tolerability study evaluated cetirizine BID (study 1, N=512), while the second study examined cetirizine three times daily (TID) (study 2, N=516). Each study assessed best corrected visual acuity, slit-lamp biomicroscopy, IOP, dilated ophthalmoscopy, treatment-emergent adverse events, vital signs, urine pregnancy test, and physical examination (general health, head, eyes, ears, nose, and throat). The PK study also measured hematology, blood chemistry, and urinalysis, while the two Phase III studies additionally assessed corneal endothelial cell counts (ECC) and ECC density in a subset of subjects (via specular microscopy), and drug administration tolerability.Bilateral administration of cetirizine ophthalmic solution 0.24% resulted in low systemic exposure in the PK study and was associated with a low incidence of mild adverse events. There were no drug-related severe or serious adverse events. The tolerability scores between the active and vehicle groups were comparable, demonstrating high comfort in the administration of cetirizine ophthalmic solution 0.24%.Cetirizine ophthalmic solution 0.24% dosed BID or TID demonstrated an acceptable safety profile and was well-tolerated when administered to subjects aged ≥2 years." @default.
- W2912113236 created "2019-02-21" @default.
- W2912113236 creator A5002159065 @default.
- W2912113236 creator A5007207249 @default.
- W2912113236 creator A5011465581 @default.
- W2912113236 creator A5083670329 @default.
- W2912113236 creator A5085096603 @default.
- W2912113236 date "2019-02-01" @default.
- W2912113236 modified "2023-09-27" @default.
- W2912113236 title "<p>Safety of cetirizine ophthalmic solution 0.24% for the treatment of allergic conjunctivitis in adult and pediatric subjects</p>" @default.
- W2912113236 cites W1997855203 @default.
- W2912113236 cites W2001748248 @default.
- W2912113236 cites W2035262371 @default.
- W2912113236 cites W2048934597 @default.
- W2912113236 cites W2049618420 @default.
- W2912113236 cites W2063088114 @default.
- W2912113236 cites W2103734191 @default.
- W2912113236 cites W2151879778 @default.
- W2912113236 cites W2158172685 @default.
- W2912113236 cites W2169736693 @default.
- W2912113236 cites W26821597 @default.
- W2912113236 cites W4290139967 @default.
- W2912113236 doi "https://doi.org/10.2147/opth.s186092" @default.
- W2912113236 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6387590" @default.
- W2912113236 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30858690" @default.
- W2912113236 hasPublicationYear "2019" @default.
- W2912113236 type Work @default.
- W2912113236 sameAs 2912113236 @default.
- W2912113236 citedByCount "9" @default.
- W2912113236 countsByYear W29121132362019 @default.
- W2912113236 countsByYear W29121132362020 @default.
- W2912113236 countsByYear W29121132362021 @default.
- W2912113236 countsByYear W29121132362022 @default.
- W2912113236 countsByYear W29121132362023 @default.
- W2912113236 crossrefType "journal-article" @default.
- W2912113236 hasAuthorship W2912113236A5002159065 @default.
- W2912113236 hasAuthorship W2912113236A5007207249 @default.
- W2912113236 hasAuthorship W2912113236A5011465581 @default.
- W2912113236 hasAuthorship W2912113236A5083670329 @default.
- W2912113236 hasAuthorship W2912113236A5085096603 @default.
- W2912113236 hasBestOaLocation W29121132361 @default.
- W2912113236 hasConcept C118487528 @default.
- W2912113236 hasConcept C126322002 @default.
- W2912113236 hasConcept C197934379 @default.
- W2912113236 hasConcept C203014093 @default.
- W2912113236 hasConcept C207480886 @default.
- W2912113236 hasConcept C2778375690 @default.
- W2912113236 hasConcept C2778715236 @default.
- W2912113236 hasConcept C2779463773 @default.
- W2912113236 hasConcept C2780870513 @default.
- W2912113236 hasConcept C42219234 @default.
- W2912113236 hasConcept C71924100 @default.
- W2912113236 hasConceptScore W2912113236C118487528 @default.
- W2912113236 hasConceptScore W2912113236C126322002 @default.
- W2912113236 hasConceptScore W2912113236C197934379 @default.
- W2912113236 hasConceptScore W2912113236C203014093 @default.
- W2912113236 hasConceptScore W2912113236C207480886 @default.
- W2912113236 hasConceptScore W2912113236C2778375690 @default.
- W2912113236 hasConceptScore W2912113236C2778715236 @default.
- W2912113236 hasConceptScore W2912113236C2779463773 @default.
- W2912113236 hasConceptScore W2912113236C2780870513 @default.
- W2912113236 hasConceptScore W2912113236C42219234 @default.
- W2912113236 hasConceptScore W2912113236C71924100 @default.
- W2912113236 hasLocation W29121132361 @default.
- W2912113236 hasLocation W29121132362 @default.
- W2912113236 hasLocation W29121132363 @default.
- W2912113236 hasLocation W29121132364 @default.
- W2912113236 hasOpenAccess W2912113236 @default.
- W2912113236 hasPrimaryLocation W29121132361 @default.
- W2912113236 hasRelatedWork W1490515507 @default.
- W2912113236 hasRelatedWork W2059313976 @default.
- W2912113236 hasRelatedWork W2089245388 @default.
- W2912113236 hasRelatedWork W2896659597 @default.
- W2912113236 hasRelatedWork W2996750011 @default.
- W2912113236 hasRelatedWork W3138587145 @default.
- W2912113236 hasRelatedWork W4283394029 @default.
- W2912113236 hasRelatedWork W4318478878 @default.
- W2912113236 hasRelatedWork W4320710015 @default.
- W2912113236 hasRelatedWork W2183331092 @default.
- W2912113236 hasVolume "Volume 13" @default.
- W2912113236 isParatext "false" @default.
- W2912113236 isRetracted "false" @default.
- W2912113236 magId "2912113236" @default.
- W2912113236 workType "article" @default.